BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 16, 2006
View Archived Issues
Vildagliptin absolute bioavailability determined in healthy subjects
Read More
Wex halts enrollment in phase IIb/III Tectin study on DMC's recommendation
Read More
BioSante presents Bio-E-Gel phase III data
Read More
Transition Therapeutics completes acquisition of Ellipsis Neurotherapeutics
Read More
Cook and AVI BioPharma enter NeuGene license agreement in vascular diseases
Read More
Allergan extends expiration of offer for Inamed
Read More
NM-702 increases peak walking time in intermittent claudication patients
Read More
Direct factor Xa inhibitor demonstrates antithrombotic activity in volunteers
Read More
Snapshots of recent studies of Berinert P in hereditary angioedema
Read More
Administration of HyperAcute prostate cancer vaccine feasible
Read More
Astex signs drug discovery collaboration with U. of Newcastle and CRT
Read More
OraSure comments on FDA's recommendations for studies of HIV home test kits
Read More
New sources for cardiac stem cell therapy
Read More
Bavarian Nordic expands capabilities for production of influenza vaccines
Read More
Callisto pursues dual development of atiprimod
Read More
Transition Therapeutics licenses GLP-1 patent portfolio for type 1 diabetes
Read More
Ventiv Health to change name to inVentiv Health
Read More
Spectrum eyes phase III trial for EOquin in H2 2006
Read More
NXY-059 safe and well tolerated in acute intracerebral hemorrhage study
Read More
Abbott supports development of HIV treatments for children
Read More
Studies of herbal agents in prostate cancer reported
Read More
Rosuvastatin 40 mg significantly reduces coronary atherosclerosis
Read More
Abciximab beneficial in some patients undergoing PCI with clopidogrel pretreatment
Read More
B2 induces inclusion formation: efficacy in cellular models of Huntington's and Parkinson's diseases
Read More
Phase I study of TGN-1412 suspended amid adverse events
Read More
Canadian approval for Vantas
Read More
Swedish approval for Grazax for grass pollen allergy
Read More
Novel agents for treating neurological disorders disclosed in recent patent literature
Read More
Recent patents disclose new therapeutic agents for depression, schizophrenia, etc.
Read More
Data from phase II clinical trial evaluating the HIV immunotherapeutic Vacc-4x reported
Read More